United States · FDA National Drug Code directory
Fexofenadine HCl and Pseudoephedrine HCI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-557_29216032-68a5-566a-5eaf-ffc9cb597e9a
- Product NDC
- 55111-557
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Fexofenadine HCl and Pseudoephedrine HCI
- Labeler
- Dr.Reddy's Laboratories Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110824
- Source listing expiry
- 20261231
Source-listed ingredients
- FEXOFENADINE HYDROCHLORIDE — 180 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE — 240 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (55111-557-07) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 55111-557-07
- 3 BLISTER PACK in 1 CARTON (55111-557-29) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 55111-557-29
- 2 BLISTER PACK in 1 CARTON (55111-557-35) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 55111-557-35
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →